{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:52:18Z","timestamp":1791229938073,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Breast implant\u2013associated anaplastic large cell lymphoma (ALCL) is a distinctive type of T-cell lymphoma that arises around breast implants. Although rare, all cases with adequate history have involved a textured breast implant. The objective of this study was to determine the U.S. incidence and lifetime prevalence of breast implant\u2013associated ALCL in women with textured breast implants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This is a retrospective review of documented cases of breast implant\u2013associated ALCL in the United States from 1996 to 2015. The incidence and prevalence were determined based on a literature and institutional database review of breast implant\u2013associated ALCL cases and textured breast implant sales figures from implant manufacturers\u2019 annualized data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      One hundred pathologically confirmed breast implant\u2013associated ALCL cases were identified in the United States. Mean age at diagnosis was 53.2 \u00b1 12.3 years. Mean interval from implant placement to diagnosis was 10.7 \u00b1 4.6 years. Forty-nine patients had breast implants placed for cosmetic reasons, 44 for mastectomy reconstruction, and seven for unknown reasons. Assuming that breast implant\u2013associated ALCL occurs only in textured breast implants, the incidence rate is 2.03 per 1 million person-years (203 per 100 million person-years), which is 67.6 times higher than that of primary ALCL of the breast in the general population (three per 100 million per year;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). Lifetime prevalence was 33 per 1 million persons with textured breast implants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This study demonstrates a statistically significant association between textured breast implants and breast implant\u2013associated ALCL. Although women with a textured breast implant have a low risk of developing breast implant\u2013associated ALCL, the current U.S. incidence is significantly higher than that of primary ALCL of the breast in the general population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/prs.0000000000003282","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T07:13:50Z","timestamp":1487056430000},"page":"1042-1050","source":"Crossref","is-referenced-by-count":295,"title":["U.S. Epidemiology of Breast Implant\u2013Associated Anaplastic Large Cell Lymphoma"],"prefix":"10.1097","volume":"139","author":[{"given":"Erin L.","family":"Doren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse C.","family":"Selber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Garvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-20230715","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006534-199708000-00065","article-title":"Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant.","volume":"100","author":"Keech","year":"1997","journal-title":"Plast Reconstr Surg"},{"key":"R4-20230715","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/PRS.0000000000001033","article-title":"Anaplastic large cell lymphoma occurring in women with breast implants: Analysis of 173 cases.","volume":"135","author":"Brody","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"R5-20230715","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cps.2015.06.006","article-title":"Coming of age: Breast implant-associated anaplastic large cell lymphoma after 18 years of investigation.","volume":"42","author":"Clemens","year":"2015","journal-title":"Clin Plast Surg"},{"key":"R6-20230715","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: Long-term follow-up of 60 patients.","volume":"32","author":"Miranda","year":"2014","journal-title":"J Clin Oncol"},{"key":"R7-20230715","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma.","volume":"34","author":"Clemens","year":"2016","journal-title":"J Clin Oncol"},{"key":"R8-20230715","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/CEJ.0b013e328350b0ae","article-title":"Risk of lymphoma in women with breast implants: Analysis of clinical studies.","volume":"21","author":"Largent","year":"2012","journal-title":"Eur J Cancer Prev"},{"key":"R9-20230715","doi-asserted-by":"crossref","first-page":"159e","DOI":"10.1097\/PRS.0b013e318213a1bd","article-title":"Null-type anaplastic lymphoma kinase-negative anaplastic large cell lymphoma arising in a silicone breast implant capsule.","volume":"127","author":"Lazzeri","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"R10-20230715","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/jama.2008.585","article-title":"Anaplastic large-cell lymphoma in women with breast implants.","volume":"300","author":"de Jong","year":"2008","journal-title":"JAMA"},{"key":"R12-20230715","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/asj\/sju084","article-title":"Ten-year results from the Natrelle 410 anatomical form-stable silicone breast implant core study.","volume":"35","author":"Maxwell","year":"2015","journal-title":"Aesthet Surg J"},{"key":"R13-20230715","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1158\/1055-9965.EPI-13-0633","article-title":"Breast implants and anaplastic large-cell lymphoma: A Danish population-based cohort study.","volume":"22","author":"Vase","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R14-20230715","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1047-2797(00)00223-4","article-title":"Cancer risk at sites other than the breast following augmentation mammoplasty.","volume":"11","author":"Brinton","year":"2001","journal-title":"Ann Epidemiol"},{"key":"R15-20230715","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/ijc.21711","article-title":"Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation.","volume":"118","author":"Brisson","year":"2006","journal-title":"Int J Cancer"},{"key":"R16-20230715","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/01.prs.0000260582.23971.02","article-title":"Cancer risk among Los Angeles women with cosmetic breast implants.","volume":"119","author":"Deapen","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R17-20230715","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ijc.21433","article-title":"Cancer risk among Danish women with cosmetic breast implants.","volume":"118","author":"Friis","year":"2006","journal-title":"Int J Cancer"},{"key":"R18-20230715","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ijc.23932","article-title":"Cancer among Scandinavian women with cosmetic breast implants: A pooled long-term follow-up study.","volume":"124","author":"Lipworth","year":"2009","journal-title":"Int J Cancer"},{"key":"R19-20230715","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/1097-0215(20001015)88:2<301::AID-IJC24>3.0.CO;2-G","article-title":"Cancer occurrence after cosmetic breast implantation in Denmark.","volume":"88","author":"Mellemkjaer","year":"2000","journal-title":"Int J Cancer"},{"key":"R20-20230715","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jnci\/djj134","article-title":"Long-term cancer risk among Swedish women with cosmetic breast implants: An update of a nationwide study.","volume":"98","author":"McLaughlin","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R21-20230715","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/bjh.13779","article-title":"Breast implants and anaplastic large cell lymphomas among females in the California Teachers Study cohort.","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Haematol"},{"key":"R22-20230715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PRS.0000000000002837","article-title":"Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants.","volume":"139","author":"McGuire","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"R23-20230715","first-page":"82","article-title":"Epidemiology and risk factors for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in Australia and New Zealand.","volume":"4","author":"Knight","year":"2016","journal-title":"Plast Reconstr Surg Global Open"},{"key":"R25-20230715","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2015.08.009","article-title":"Silicone implants and lymphoma: The role of inflammation.","volume":"65","author":"Bizjak","year":"2015","journal-title":"J Autoimmun"},{"key":"R26-20230715","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/PRS.0000000000002010","article-title":"Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma.","volume":"137","author":"Hu","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"R27-20230715","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/PRS.0000000000000886","article-title":"Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: Implications for breast implant-associated lymphoma.","volume":"135","author":"Hu","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"R28-20230715","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/asj\/sjw023","article-title":"Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma.","volume":"36","author":"Kadin","year":"2016","journal-title":"Aesthet Surg J"},{"key":"R29-20230715","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/PRS.0b013e3182a3c105","article-title":"The role of bacterial biofilms in device-associated infection.","volume":"132","author":"Deva","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"R30-20230715","doi-asserted-by":"crossref","first-page":"471e","DOI":"10.1097\/PRS.0000000000000020","article-title":"In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants.","volume":"133","author":"Jacombs","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"R31-20230715","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/01.prs.0000481103.45976.b1","article-title":"Breast implant informed consent should include the risk of anaplastic large cell lymphoma.","volume":"137","author":"Clemens","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"R32-20230715","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/asj\/sjw259","article-title":"NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma.","volume":"37","author":"Clemens","year":"2017","journal-title":"Aesthet Surg J"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006534-201705000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T01:04:14Z","timestamp":1689383054000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006534-201705000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000003282","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}